Skip to main content
SpringerLink
Log in
Book cover

Eicosanoids, Apolipoproteins, Lipoprotein Particles, and Atherosclerosis pp 283–287Cite as

Quantitative Abnormalities of Lipoprotein Particle in Chronic Hemodialysis Patients

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 243))

Abstract

Complex and characteristic abnormalities have been described in chronic renal failure (CRF) patients treated by hemodialysis. Hypertriglyceridemia is the most usual abnormality associated with an increased level of the triglyceride content of very low density lipoproteins (VLDL) which represent a mixture of particles differing in density, size, charge distribution and apolipoprotein (apo) composition1. In normolipidemic subjects these particles contain various combinations of apolipoproteins B, C and E with the major lipoprotein species LpB:C:E characterized by the presence of all three apolipoproteins2. Recent studies tend to establish whether CRF is characterized by a specific apolipoprotein profile3,4b y determining the levels of the different apolipoproteins in this disease.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. P. Puchois, P. Alaupovic, and J.C. Fruchart, Mise au point sur les classifications des lipoproteines plasmatiques, Ann. Biol. Clin. 43:831 (1985).

    CAS  Google Scholar 

  2. P. Alaupovic, C.S. Wang, W.J. McConathy, D. Wei ser, and D. Downs, Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase : the identification of lipoprotein B as the main lipoprotein degradation product, Arch Biochem. Biophys. 244:226 (1986).

    Article  PubMed  CAS  Google Scholar 

  3. P.O. Attman, P. Alaupovic, C. Knight, C.S. Wang, and H. Bass, Apolipoprotein pattern in patients with chronic renal failure, Contr. Nephrol. 41:328 (1984).

    CAS  Google Scholar 

  4. P. O. Attman, P. Alaupovic, and A. Gustafson, Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int. 32:368 ( 1987).

    Article  PubMed  CAS  Google Scholar 

  5. D. Parsy, M. Draeon, C. Cachera, H.J. Parra, G. Vanhoutte, A. Tacquet, and J.C. Fruchart, Lipoprotein abnormalities in chronic haemodialysis patients. Nephrology Dialysis and Transplantation (in press), 1988.

    Google Scholar 

  6. M.J. McConathy, and P. Alaupovic, Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence of the specific binding of lipoprotein B in its associated and free forms, FEBS Let. 41:174 (1974).

    Article  CAS  Google Scholar 

  7. E. Koren, P. Puchois, P. Alaupovic, J. Fesmire, A. Kandoussi, and J.C. Fruchart, Quantification of two different types of apolipoprotein A-I containing lipoprotein particles in plasma by enzymelinked differential-antibody immunosorbent assay, Clin. Chem. 33:38 (1987).

    PubMed  CAS  Google Scholar 

  8. A. Kandoussi, P. Puchois, D. Parsy, and J.C. Fruchart, Quantitative determination of different apo B containing lipoproteins by an enzyme linked immunosorbent assay : lipoprotein containing apo B and C-III, apo B and E.J. Lipid Res., Submitted for publication.

    Google Scholar 

  9. J.C. Fruchart, P. Duthilleul, A. Daunizeau, and P. Comyn, Dosage du cholesterol total a l’aide d’une methode enzymatique utilisant un monoreactif, Pharm. Biol. 24:227 (1980).

    Google Scholar 

  10. J. Ziegenhorn, K. Baril, and R. Deeg, Improved kinetic method for automated determination of serum triglycerides, CIin. Chem. 26:973 (1980).

    Google Scholar 

  11. M. Takayama, S. Itoh, and T. Nagasaki, A new enzymatic method for determination of serum cholin containing phospholipids, Clin. Chim. Acta 79:93 (1977).

    Article  PubMed  CAS  Google Scholar 

  12. T.H. Grove, Effet of nagent pH on determination of high density lipoprotein cholesterol by precipitation with sodium phosphotungstate-magnesium, Clin. Chem. 25:560 (1979).

    PubMed  CAS  Google Scholar 

  13. J.C. Fruchart, C. Fievet, and P. Puchois, Apo-lipoproteins, in: “Methods of Enzymatic Analysis” H.U. Bergmeyer, ed., Verlag Chemie (1985).

    Google Scholar 

  14. D. Parsy, V. Clavey, C. Fievet, I. Kora, P. Duriez, and J.C. Fruchart, Quantification of apolipoprotein C-III in serum by a non competitive immunoenzymometric assay, Clin. Chem. 31:1632 (1985).

    PubMed  CAS  Google Scholar 

  15. M. Koffigan, I. Kora, V. Clavey, J.M. Bard, J. Chapman, and J.C. Fr uchart, Quantification of human apolipoprotein E in plasma and lipoprotein subfractions by a non-competitive enzyme immunoassay, Clin. Chim. Acta 163:245 (1987),

    Article  PubMed  CAS  Google Scholar 

  16. R. Hahn, K. Oette, H. Mondorf, K. Finke, E.G. Sieberth, Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias, Atherosclerosis 48:279 (1983).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut Pasteur, SERLIA et Inserm U 279, Lille, France

    H. J. Parra, C. Cachera & J. C. Fruchart

  2. UER de Pharmacie de Lille II, Lille, France

    C. Cachera & J. C. Fruchart

  3. Laboratoire de Recherches Néphrologiques, Hôpital Calmette, Lille, France

    C. Cachera, K. Equagoo, M. Dracon & A. Tacquet

Authors
  1. H. J. Parra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Cachera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Equagoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Dracon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. C. Fruchart
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Tacquet
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Research Foundation on Atherosclerosis, Brussels, Belgium

    Claude L. Malmendier

  2. The Free University of Brussels, Brussels, Belgium

    Claude L. Malmendier

  3. Lipoprotein and Atherosclerosis Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA

    Petar Alaupovic

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Press, New York

About this chapter

Cite this chapter

Parra, H.J., Cachera, C., Equagoo, K., Dracon, M., Fruchart, J.C., Tacquet, A. (1988). Quantitative Abnormalities of Lipoprotein Particle in Chronic Hemodialysis Patients. In: Malmendier, C.L., Alaupovic, P. (eds) Eicosanoids, Apolipoproteins, Lipoprotein Particles, and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 243. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0733-4_36

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0733-4_36

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8055-2

  • Online ISBN: 978-1-4613-0733-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation